ČESKÁ UROLOGIE / CZECH UROLOGY – 2 / 2020

104 PŘEHLEDOVÝ ČLÁNEK Ces Urol 2020; 24(2): 100–104 7. Meye A, Bilkenroth U, Schmidt U, et al. Isolation and enrichment of urologic tumor cells in blood sam‑ ples by a semi‑automated CD45 depletion autoMACS protocol. Int J Oncol 2002; 21: 521–530. 8. Bluemke K, Bilkenroth U, Meye A, et al. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2190–2194. 9. Shimazui T, Yoshikawa K, Uemura H, et al. Detection of cadherin-6 mRNA by nested RT‑PCR as a po‑ tential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol 2003; 23: 1049–1054. 10. Li G, Passebosc‑Faure K, GentilPerret A, et al. Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells. Anticancer Res. 2005; 25: 377–381. 11. Buchner A, Riesenberg R, Kotter I, et al. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma. Cancer 2006; 106: 1514–1520. 12. Basso U, Facchinetti A, Rossi E, et al. Prognostic role of circulating tumor cells‑CTCs in metastatic renal cell carcinoma. J Clin Oncol. 2017; 35: 4568–4568. 13. Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumour cells‑biology and bio‑ markers. Nat Rev Clin Oncol. 2014; 11: 129–144. 14. Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell‑mediated elimination of tumor cells. Blood 2005; 105: 178–185. 15. Zhang D, Zhao L, Zhou P, et al. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size‑based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy. Cancer Cell Int. 2017; 17: 6. 16. Hou JM, KrebsMG, Lancashire L, et al. Clinical significance andmolecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small‑cell lung cancer. J Clin Oncol. 2012; 30: 525–532. 17. Nagaya N, Kanayama M, Nagata M, Horie S. The Surge in the Number of Circulating Tumor Cells Fo‑ llowing Treatment with Sunitinib for Metastatic Renal Cell Carcinoma. Intern Med. 2018; 57(18): 2695–2700. ◼ Urologická léčba roztroušené sklerózy ◼ Léčba následků dlouhodobě navlečeného perlátoru na kořen penisu ◼ Prevence recidivujících cystitid pomocí roztoku hyaluronátu sodného ◼ Segmentální infarkt varlete: orchiektomie vs. sledování ◼ Parciální amputace penisu jako léčba verukózního karcinomu Do České urologie č. 3 / 2020 připravujeme